Chronic pancreatitis
Jörg Kleeff(University Hospital in Halle), John P. Neoptolemos(University of Liverpool), David C. Whitcomb(Christian Medical College & Hospital), Tooru Shimosegawa(Japan Pancreatic Disease Research Foundation), Asbjørn Mohr Drewes(Aalborg University Hospital), Iréne Esposito(Heinrich Heine University Düsseldorf), Fatih Akisik(Indiana University School of Medicine), Thomas M. Gress(Universitätsklinikum Gießen und Marburg), J. Enrique Domínguez‐Muñoz(Universidade de Santiago de Compostela), Vinciane Rebours(Hôpital Beaujon), Markus M. Lerch(Ludwig-Maximilians-Universität München), Julia Mayerle(LMU Klinikum)
Cited by 447
Related Papers
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
|Nature Genetics|1996|1.6k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Chronic pancreatitis: Diagnosis, classification, and new genetic developments
|Gastroenterology|2001|1.2k